Defunct Company
Total Trials
10
As Lead Sponsor
2
As Collaborator
8
Total Enrollment
3,349
NCT00805701
Study Assessing The Efficacy And Safety Of Avodart (Dutasteride) At Improving Urinary Symptoms In Men With Prostate Cancer Who Are Undergoing Seed Implantation
Phase: Phase 4
Role: Lead Sponsor
Start: Jan 31, 2009
Completion: Apr 30, 2014
NCT01084239
Multicenter Study to Rule Out Myocardial Infarction by Cardiac Computed Tomography
Phase: Phase 3
Role: Collaborator
Start: Apr 30, 2010
Completion: Mar 31, 2012
NCT01764893
Use of Percutaneous Tibial Nerve Stimulation With Solifenacin or Placebo to Treat Refractory Overactive Bladder
Start: Jan 31, 2013
NCT02855697
Multi-maintenance Olaparib After Disease Recurrence in Participants With Platinum Sensitive BRCAm High Grade Serous Ovarian Cancer
Phase: Early Phase 1
Start: May 26, 2017
Completion: Dec 31, 2021
NCT03249207
SC IL-1Ra in SAH - Phase III Trial (SCIL)
Start: Oct 11, 2018
Completion: Sep 30, 2024
NCT03950388
Trial of a Ward-Based Intervention to Improve Access to Psychologically-Informed Care and Psychological Therapy for Mental Health In-Patients
Phase: N/A
Start: Oct 21, 2019
Completion: Jun 30, 2022
NCT03815006
Flash-glucose Monitoring in Sub-optimally Controlled Type 1 Diabetes (FLASH-UK)
Start: Jan 9, 2020
Completion: Oct 10, 2021
NCT04208464
JAK 1/2 Inhibitor, Baricitinib, in the Treatment of Adult IIM
Phase: Phase 2
Start: Oct 7, 2021
Completion: Sep 25, 2023
NCT05518305
Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis
Start: Sep 30, 2022
Completion: Sep 30, 2027
NCT06874504
Clinical Validation of the Norbert Health Device for Pulse Rate Measurement
Start: Mar 13, 2025
Completion: Apr 11, 2025